We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-25.93%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$108M
Cap. Flow %
108.1%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RUBY
Rubius Therapeutics, Inc
RUBY
+$47.7M
2
FATE icon
Fate Therapeutics
FATE
+$28.9M
3
KURA icon
Kura Oncology
KURA
+$24.6M
4
CHMA
Chiasma, Inc. Common Stock
CHMA
+$4.29M
5
AKAO
Achaogen Inc
AKAO
+$1.67M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
$42.1M 42.09%
+2,618,351
New +$47.7M
FATE icon
2
Fate Therapeutics
FATE
$290M
$26.6M 26.59%
+2,073,190
New +$28.9M
KURA icon
3
Kura Oncology
KURA
$916M
$26.1M 26.06%
+1,856,307
New +$24.6M
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.72M 3.72%
+1,196,776
New +$4.29M
BLPH
5
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$774K 0.77%
+64,377
New +$935K
AKAO
6
DELISTED
Achaogen Inc
AKAO
$768K 0.77%
+624,544
New +$1.67M

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Arch Venture Management, which disclosed 6 positions worth $100M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Rubius Therapeutics, Inc: 2,618,351 shares worth $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets.

  • Arch Venture Management's largest Q4 2018 buy was Rubius Therapeutics, Inc: 2,618,351 shares worth $42.1M.
  • Arch Venture Management's ten largest holdings make up 100% of its $100M portfolio in Q4 2018.
  • Arch Venture Management disclosed 6 positions in Q4 2018, its first 13F filing on record.

Based on Arch Venture Management's 13F filing for Q4 2018, filed 14 Feb 2019.